Limited data are available regarding the use of neuromuscular blocking agents (NMBAs) in cardiac pediatric patients. NMBAs are commonly administered to facilitate tracheal intubation and surgical ...

12023Background: Anthracyclines, such as doxorubicin, and HER-2 blocking agents, like trastuzumab, are integral in breast cancer treatment but are associated with significant cardiotoxicity.

UPPSALA, SE / ACCESS Newswire / July 23, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime today announced that its TetraGraph system has received approval from the Mexican Secretariat of Health (COFEP ...

Sugammadex (Bridion; Merck) administered to reverse the neuromuscular blockade patients with myasthenia gravis undergo during surgery is safe and effective in this setting, with potential for ...

Background: Neuromuscular blocking agents (NMBAs) are primarily used during surgical procedures to facilitate endotracheal intubation and optimize surgical conditions. This study aimed to explore the ...

Effect of fructose on anthracycline and HER-2 blocking agent mediated cardiotoxicity through NLRP3 and MyD88 mediated pathways: New roles of sweeteners in cardio-oncology.. If you have the appropriate ...

Dec 30, 2023 Share this article: The following is a summary of “Neuromuscular blocking agent re-exposure in a retrospective cohort with neuromuscular blocking agent–associated anaphylaxis,” published ...

The phenomena of residual curarisation and recurarisation after the use of long-acting non-depolarising neuromuscular blocking drugs such as tubocurarine and pancuronium were well recognised 60 years ...

Industry Voices—TEFCA and information blocking: The end of patient digital access to their chart?